tiprankstipranks
Advertisement
Advertisement

RDHL Stock Latest News

RedHill Biopharma Shareholders Approve Leadership Changes and Share Structure Amendment
Company AnnouncementsRedHill Biopharma Shareholders Approve Leadership Changes and Share Structure Amendment
19d ago
6K
RDHL
RedHill Biopharma Reschedules Quorum-Delayed AGM to August 7
PremiumCompany Announcements
RedHill Biopharma Reschedules Quorum-Delayed AGM to August 7
20d ago
6K
RDHL
RedHill Biopharma Advances Opaganib as Ebola Outbreak Worsens
PremiumCompany Announcements
RedHill Biopharma Advances Opaganib as Ebola Outbreak Worsens
29d ago
6K
RDHL
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
PremiumCompany Announcements
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
2M ago
6K
RDHL
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
PremiumCompany Announcements
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
2M ago
6K
RDHL
RedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
PremiumCompany AnnouncementsRedHill Biopharma Sets July 28, 2026 AGM to Vote on Board, Auditor and Chairman-CEO Role
2M ago
6K
RDHL
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
Premium
Company Announcements
RedHill Biopharma Closes $6 Million Private Placement to Fund Potential Acquisition
2M ago
6K
RDHL
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
Premium
Company Announcements
RedHill Biopharma Raises $6 Million in June 2026 Private Placement of ADSs and Warrants
2M ago
6K
RDHL
RedHill Biopharma Sets July 28, 2026 Shareholder Meeting to Vote on Board, CEO-Chairman Role
PremiumCompany Announcements
RedHill Biopharma Sets July 28, 2026 Shareholder Meeting to Vote on Board, CEO-Chairman Role
2M ago
6K
RDHL
RedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
PremiumCompany Announcements
RedHill Biopharma Secures Up to $19.4 Million in Private Placement to Fund Pipeline and Potential Acquisition
2M ago
6K
RDHL
RedHill Biopharma announces $19.4M private placement
PremiumThe Fly
RedHill Biopharma announces $19.4M private placement
2M ago
RDHL
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
PremiumMarket News
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
2M ago
GILD
JAZZ
RedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst
PremiumMarket NewsRedHill Biopharma’s Opaganib Ebola Plan Gives RDHL Stock a New Catalyst
3M ago
GILD
RDHL
RedHill Biopharma Wins FDA Rare Pediatric Disease Designation for Opaganib in Neuroblastoma
Premium
Company Announcements
RedHill Biopharma Wins FDA Rare Pediatric Disease Designation for Opaganib in Neuroblastoma
3M ago
6K
RDHL
RedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation
Premium
The Fly
RedHill Biopharma’s opaganib granted FDA Rare Pediatric Disease designation
3M ago
RDHL
RedHill Biopharma Moves to Enforce $10.9 Million New York Judgment Against Kukbo in Korea
PremiumCompany Announcements
RedHill Biopharma Moves to Enforce $10.9 Million New York Judgment Against Kukbo in Korea
3M ago
6K
RDHL
RedHill Biopharma launches enforcement of $11M judgment against Kukbo
PremiumThe Fly
RedHill Biopharma launches enforcement of $11M judgment against Kukbo
3M ago
RDHL
RedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
PremiumThe Fly
RedHill Biopharma advancing opaganib options for Ebola outbreak biodefense
3M ago
RDHL
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
PremiumCompany Announcements
RedHill Biopharma Moves to Advance Opaganib as Oral Antiviral Option for Current Ebola Outbreak
3M ago
6K
RDHL
RedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
PremiumCompany AnnouncementsRedHill Biopharma Expands At-The-Market ADS Offering to Boost Capital Flexibility
3M ago
6K
RDHL
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
Premium
Company Announcements
RedHill Biopharma Reports Promising MAP-Killing Data for Next-Generation Crohn’s Candidate RHB-204
4M ago
6K
RDHL
RedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
Premium
The Fly
RedHill Biopharma’s RHB-204 shows efficacy in Crohn’s Disease
4M ago
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >